Fig. 1
From: DDX52 knockdown inhibits the growth of prostate cancer cells by regulating c-Myc signaling
DDX52 is overexpressed in human prostate cancer (PCa) and is associated with poor outcomes. a DDX52 expression in normal prostate tissues and PCa tissues was examined using immunohistochemistry (IHC) (Mann–Whitney test, error bars represent standard deviations; ***p < 0.001). b Representative photographs of normal prostate tissues and PCa tissues (scale bar: 100 μm). c, d DDX52 expression in the indicated human prostate tissues (data derived from the Gene Expression Omnibus datasets GSE6919 and GSE35988) (t-test; *p < 0.05; **p < 0.01). e Kaplan–Meier plot revealing differences in the probability of survival between 25% higher DDX52 expression and 25% lower DDX52 expression in cohorts of advanced PCa patients